Linagliptin diabetes drug. Tablet of the drug linagliptin, marketed under the name Trajenta, used to treat type 2 (non-insulin dependent) diabetes. Linagliptin works by inhibiting an enzyme that inactivates hormones that remove glucose from the blood. This helps to keep blood glucose levels under control. | |
Licence : | Droits gérés |
Crédit: | Science Photo Library / Marazzi, Dr. P. |
Taille de l’image : | 5342 px × 3565 px |
Model Release : | Non requis |
Restrictions : |
|